A Huge Global Fund Likes These Healthcare Stocks

Following is information regarding Man Investments’ top holdings in the Healthcare sector for the quarter ending September 30th, 2011:

  • Procter & Gamble Co. (NYSE:PG): On 6/30/11 Man Investments reported holding 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. On 9/30/11, Man Investments held 10,620 shares with a market value of $670,972. This comprised 2.15% of the total portfolio. The net change in shares for this position over the two quarters is 10,620. About the company: The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Proctor & Gamble’s products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
  • AmerisourceBergen Corporation (NYSE:ABC): On 6/30/11 Man Investments reported holding 15,188 shares with a market value of $628,783. This comprised 0.48% of the total portfolio. On 9/30/11, Man Investments held 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. The net change in shares for this position over the two quarters is -15,188. About the company: AmerisourceBergen Corporation is a pharmaceutical services company. The Company distributes pharmaceutical products and services. AmerisourceBergen distributes an offering of brand name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers.
  • Abbott Laboratories (NYSE:ABT): On 6/30/11 Man Investments reported holding 12,138 shares with a market value of $638,702. This comprised 0.49% of the total portfolio. On 9/30/11, Man Investments held 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. The net change in shares for this position over the two quarters is -12,138. About the company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Amerigroup Corporation (NYSE:AGP): On 6/30/11 Man Investments reported holding 10,009 shares with a market value of $705,334. This comprised 0.54% of the total portfolio. On 9/30/11, Man Investments held 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. The net change in shares for this position over the two quarters is -10,009. About the company: AMERIGROUP Corporation, a multi-state managed healthcare company, serves people who receive healthcare benefits through state-sponsored programs. Programs include Medicaid, Children’s Health Insurance Program, and Family Care. The Company provides managed care and medical management programs, as well as offers community-based education and outreach programs.
  • Amedisys, Inc. (NASDAQ:AMED): On 6/30/11 Man Investments reported holding 23,948 shares with a market value of $637,735. This comprised 0.49% of the total portfolio. On 9/30/11, Man Investments held 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. The net change in shares for this position over the two quarters is -23,948. About the company: Amedisys, Inc. is a multi-regional provider of alternate-site health care services. The Company offers home health care nursing, home infusion therapy, and ambulatory surgery centers. Amedisys operates offices within a network of subsidiaries in the southern and southeastern United States.
  • Amgen, Inc. (NASDAQ:AMGN): On 6/30/11 Man Investments reported holding 10,697 shares with a market value of $624,170. This comprised 0.48% of the total portfolio. On 9/30/11, Man Investments held 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. The net change in shares for this position over the two quarters is -10,697. About the company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Becton, Dickinson & Co. (NYSE:BDX): On 6/30/11 Man Investments reported holding 7,476 shares with a market value of $644,207. This comprised 0.49% of the total portfolio. On 9/30/11, Man Investments held 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. The net change in shares for this position over the two quarters is -7,476. About the company: Becton, Dickinson and Company manufactures and sells a variety of medical supplies and devices and diagnostic systems. The Company’s products are used by health care professionals, medical research institutions, and the general public. Becton’s products are marketed worldwide.
  • Biogen Idec, Inc. (NASDAQ:BIIB): On 6/30/11 Man Investments reported holding 6,535 shares with a market value of $698,722. This comprised 0.54% of the total portfolio. On 9/30/11, Man Investments held 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. The net change in shares for this position over the two quarters is -6,535. About the company: Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company’s products addresses diseases such as multiple sclerosis, non-Hodgkin’s lymphoma, rheumatoid arthritis, crohn’s disease, and psoriasis.
  • Bristol-Myers Squibb Co. (NYSE:BMY): On 6/30/11 Man Investments reported holding 21,289 shares with a market value of $616,529. This comprised 0.47% of the total portfolio. On 9/30/11, Man Investments held 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. The net change in shares for this position over the two quarters is -21,289. About the company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Cardinal Health, Inc (NYSE:CAH): On 6/30/11 Man Investments reported holding 14,365 shares with a market value of $652,458. This comprised 0.50% of the total portfolio. On 9/30/11, Man Investments held 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. The net change in shares for this position over the two quarters is -14,365. About the company: Cardinal Health, Inc. provides complementary products and services to healthcare providers and manufacturers. The Company’s services include pharmaceutical distribution, health-care product manufacturing, distribution and consulting services, drug delivery systems development, pharmaceutical packaging, automated dispensing systems manufacturing, and retail pharmacy franchising.

(Note: Data regarding Man Investments’ stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet